Preliminary Final Report
| Stock | Heramed Ltd (HMD.ASX) |
|---|---|
| Release Time | 28 Feb 2025, 4:56 p.m. |
| Price Sensitive | Yes |
HeraMED Limited Releases Preliminary Final Report
- Revenues down 20.6% to $481,227
- Loss from ordinary activities down 19.0% to $5,490,578
- Net tangible assets per ordinary security at $0.23
HeraMED Limited has released its preliminary final report for the year ended 31 December 2024. The company's revenues from ordinary activities decreased by 20.6% to $481,227, while the loss from ordinary activities after tax attributable to the owners of HeraMED Limited decreased by 19.0% to $5,490,578. The loss for the consolidated entity after providing for income tax amounted to $5,490,578, compared to $6,775,173 in the previous year. The net tangible assets per ordinary security increased from -$0.08 in the previous period to $0.23 in the reporting period. There were no dividends paid, recommended or declared during the current or previous financial period, and the company did not gain or lose control over any entities. The financial statements have been audited and an unmodified opinion has been issued.